Distribution of enrofloxacin within the bronchoalveolar region of healthy pigs
- PMID: 36653162
- PMCID: PMC10076201
- DOI: 10.1292/jvms.22-0416
Distribution of enrofloxacin within the bronchoalveolar region of healthy pigs
Abstract
This study aimed to elucidate the distribution of enrofloxacin (ERFX) within the bronchoalveolar region of pigs. Six clinically healthy pigs were allocated to intramuscular treatments with either a single dose of 5 mg/kg or 7.5 mg/kg ERFX. Samples of plasma and bronchoalveolar lavage fluid (BALF) were obtained from each pig 0 (before administration), 3, 8, and 24 hr after ERFX administration. The ERFX concentrations in pulmonary epithelial lining fluid (ELF) and BALF cells showed a similar pattern during the experimental period, whereby ERFX concentrations in both ELF and BALF cells were higher than those in the plasma. These results suggest that intramuscularly injected ERFX is well-distributed in the bronchoalveolar region.
Keywords: bronchoalveolar lavage fluid; distribution; enrofloxacin; pig.
Conflict of interest statement
The authors have no conflict of interest to declare. This study was supported by grants from the Bayer Yakuhin Ltd (Elanco Japan K.K.).
Figures
References
-
- Bimazubute M, Cambier C, Baert K, Vanbelle S, Chiap P, Albert A, Delporte JP, Gustin P. 2010. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. J Vet Pharmacol Ther 33: 183–188. doi: 10.1111/j.1365-2885.2009.01123.x - DOI - PubMed
-
- Blondeau JM, Fitch SD. 2019. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis. PLoS One 14: e0210154. doi: 10.1371/journal.pone.0210154 - DOI - PMC - PubMed
